Chemical researchers grappling with frequent syringe changes during reactions may find relief in Radleys' latest innovation. The company has unveiled a new syringe pump solution tailored for users of its AVA software platform, designed to optimize liquid delivery precision and efficiency in chemical processes.
Precise reagent addition remains fundamental to controlled chemical reactions. Traditional syringe pumps often require mid-experiment replacements due to capacity limitations - a time-consuming process that risks introducing errors. Radleys' solution centers on the RR20418 single syringe pump, part of the RR20504 pump expansion module, which accommodates standard syringes up to 60ml. For higher-volume needs, researchers can utilize 140ml syringes, achieving practical working capacities of 120-125ml.
This expanded capacity significantly extends continuous delivery periods, minimizing manual intervention while improving experimental reproducibility and reliability.
The system's integration with Radleys' AVA software represents a key advancement. As a comprehensive reaction control and data acquisition platform, AVA enables real-time monitoring and adjustment of reaction parameters. Through this interface, users can precisely program:
This functionality supports complex dosing protocols, allowing researchers to fine-tune reaction conditions for improved yield and selectivity.
The system's user-friendly design accommodates both experienced researchers and new laboratory personnel, while Radleys' comprehensive support infrastructure ensures optimal implementation.
This development reflects Radleys' ongoing dedication to innovative laboratory solutions. By combining high-capacity fluid handling with advanced software control, the company provides researchers with tools to push boundaries in chemical discovery and process optimization.
Based in Saffron Walden, Essex (UK), Radleys continues to serve the global research community with high-performance laboratory equipment, maintaining its focus on customer-centric innovation and scientific excellence.
Chemical researchers grappling with frequent syringe changes during reactions may find relief in Radleys' latest innovation. The company has unveiled a new syringe pump solution tailored for users of its AVA software platform, designed to optimize liquid delivery precision and efficiency in chemical processes.
Precise reagent addition remains fundamental to controlled chemical reactions. Traditional syringe pumps often require mid-experiment replacements due to capacity limitations - a time-consuming process that risks introducing errors. Radleys' solution centers on the RR20418 single syringe pump, part of the RR20504 pump expansion module, which accommodates standard syringes up to 60ml. For higher-volume needs, researchers can utilize 140ml syringes, achieving practical working capacities of 120-125ml.
This expanded capacity significantly extends continuous delivery periods, minimizing manual intervention while improving experimental reproducibility and reliability.
The system's integration with Radleys' AVA software represents a key advancement. As a comprehensive reaction control and data acquisition platform, AVA enables real-time monitoring and adjustment of reaction parameters. Through this interface, users can precisely program:
This functionality supports complex dosing protocols, allowing researchers to fine-tune reaction conditions for improved yield and selectivity.
The system's user-friendly design accommodates both experienced researchers and new laboratory personnel, while Radleys' comprehensive support infrastructure ensures optimal implementation.
This development reflects Radleys' ongoing dedication to innovative laboratory solutions. By combining high-capacity fluid handling with advanced software control, the company provides researchers with tools to push boundaries in chemical discovery and process optimization.
Based in Saffron Walden, Essex (UK), Radleys continues to serve the global research community with high-performance laboratory equipment, maintaining its focus on customer-centric innovation and scientific excellence.